NOVÉ ANTIKOAGULANCIÁ A ICH VÝZNAM U PACIENTOV S FIBRILÁCIOU PREDSIENÍ A RIZIKOM CIEVNEJ MOZGOVEJ PRÍHODY
![PDF) Manažment krvácania pri liečbe priamymi perorálnymi antikoagulanciami (Management of bleeding under treatment with direct oral anticoagulants) PDF) Manažment krvácania pri liečbe priamymi perorálnymi antikoagulanciami (Management of bleeding under treatment with direct oral anticoagulants)](https://i1.rgstatic.net/publication/366250374_Manazment_krvacania_pri_liecbe_priamymi_peroralnymi_antikoagulanciami_Management_of_bleeding_under_treatment_with_direct_oral_anticoagulants/links/6399bfd111e9f00cda42aab0/largepreview.png)
PDF) Manažment krvácania pri liečbe priamymi perorálnymi antikoagulanciami (Management of bleeding under treatment with direct oral anticoagulants)
Čo potrebujeme vedieť o analgetickom účinku kombinácie vysokých dávok vitamínov B pri bolesti chrbta
SÚHRN CHARAKTERISTICKÝCH VLASTNOSTÍ LIEKU 1. NÁZOV LIEKU Apixaban Mylan 2,5 mg filmom obalené tablety 2. KVALITATÍVNE A KV
![PDF) Apixaban for the treatment of cancer-associated venous thromboembolism and left atrial appendage thrombus refractory to optimal anticoagulation with warfarin: a case report PDF) Apixaban for the treatment of cancer-associated venous thromboembolism and left atrial appendage thrombus refractory to optimal anticoagulation with warfarin: a case report](https://i1.rgstatic.net/publication/329214894_Apixaban_for_the_treatment_of_cancer-associated_venous_thromboembolism_and_left_atrial_appendage_thrombus_refractory_to_optimal_anticoagulation_with_warfarin_a_case_report/links/5bfd4ea3299bf1c2329d61c2/largepreview.png)